Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dZrDCfbwoceTchslvXCR

  ADVERTISEMENT  
November 13, 2012News for the transfusion medicine and cellular therapy community

  Top Story 
  Science & Health 
  • Islet cell transplants could lead to diabetes cure
    Dr. Camillo Ricordi is working with other scientists at the University of Miami's Diabetes Research Institute on transplanting islet cells into patients with type 1 diabetes. Half of those treated were able to stay off insulin for five years, comparable with patients who received pancreas transplants. Researchers are working on ways, such as encapsulation, to make the transplanted cells survive longer and minimize use of antirejection drugs. The Miami Herald (free registration) (11/10) LinkedInFacebookTwitterEmail this Story
  Emerging Trends 
  Industry News & Practice 
  • EarlySense gets $15M for blood oxygen tracking system
    EarlySense will use $15 million from a funding round to bring to the market an FDA-cleared oxygen saturation component for its patient-monitoring system. The device allows the continuous, automatic tracking of oxygen levels in the blood and monitors movement to help prevent bedsores, which can increase the risk of hospital-acquired infections. MedCityNews.com (11/12) LinkedInFacebookTwitterEmail this Story
  • Program develops method to treat blood loss-related injuries
    MRC Technology has received $916,000 from the U.K. Biomedical Catalyst for research that will explore the function of cytokine IL-16 in ischemic reperfusion injury, which is caused by the sudden loss of blood flow during surgery or following a blood clot. The program aims to develop a humanized anti-IL-16 antibody that will be used in animal models and eventually in studies of patients. Genetic Engineering & Biotechnology News (11/12) LinkedInFacebookTwitterEmail this Story
  • Boehringer plans late-stage trial of hepatitis C drugs
    Boehringer Ingelheim plans to begin a Phase III study of its hepatitis C regimen after obtaining positive results from a midstage trial. The SOUND-C2 study found that 69% of patients who received a combination of BI-201335, a protease inhibitor, and BI-207127, a polymerase inhibitor, plus ribavirin, were virus-free 12 and 24 weeks after completing therapy. CNBC/Reuters (11/10) LinkedInFacebookTwitterEmail this Story
The Buzz(CORPORATE ANNOUNCEMENTS)

Certified Quality Auditor Question Bank
Simulate the CQA exam from the convenience of your home or office. ASQ's online certification preparation course teaches you the concepts you'll see on your test, and provides practice exams so you can review the material. This gives you the best chance to learn effectively and pass your exam. All for as little as $99.


  Government & Regulatory 
  • DHS awards $3M emergency data mining contract for social media
    The Department of Homeland Security has awarded Accenture Federal Services a one-year, $3 million deal to assist the Office of Health Affairs in improving its biosurveillance capabilities. A social media analytics pilot program will be launched by Accenture to connect, assess and oversee information from social media networks in real time, for use in times of biological attacks or outbreaks of infectious diseases. Modern Healthcare (subscription required) (11/8) LinkedInFacebookTwitterEmail this Story
  Association News 
  • Reminder: Deadline approaching to submit proposals for 2013 Annual Meeting educational program
    The deadline to submit educational session proposals for the upcoming 2013 Annual Meeting and CTTXPO in Denver is Nov. 16. Proposals should be for 90-minute and three-hour programs focused on cellular therapies, patient blood management, leadership management, quality education, scientific issues and technical/clinical issues. For more information, contact the AABB Education and Professional Development department. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
West Coast Account ManagerMacopharma USAUS - Nationwide
VP Patient ServicesBlood Centers of the PacificUS - CA - San Francisco
Director, LaboratorySan Diego Blood BankUS - CA - San Diego
Quality Source ConsultantBlood Systems, Inc.US - Nationwide
Quality SpecialistBlood Systems, Inc.US - NM - Albuquerque
Immunohematology Reference TechnologistLifeStreamUS - CA - San Bernardino
Director, Patient Blood ManagementAABBUS - MD - Bethesda
Help Desk SpecialistAABBUS - MD
Staff AccountantAABBUS - MD
Click here to view more job listings.

  SmartQuote 
For the happiest life, rigorously plan your days, leave your nights open to chance."
--Mignon McLaughlin,
American author and journalist


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information